News › Clinical Practice, Industry News, Patient Care

New Study Uncovers Genetic Links to Rosacea

April 1, 2015

Researchers have identified gene variants that suggest a genetic component for rosacea, which could lead to new treatment targets and a better understanding of this incurable skin disease.
In a study published online in the Journal of Investigative Dermatology (March 12, 2015), researchers from Stanford University’s department of dermatology and 23andMe, a personal genetics company, studied data from nearly 23,000 of the genetics company’s clients, including 2,618 rosacea cases. They identified two rosacea-associated single nucleotide polymorphisms (SNPs), one which replicated in another group of 29,481 people, including 3,205 rosacea cases.
Read more at Dermatology Times.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement
    • Boulevard Launches ePrescribe for Direct In-Platform Med Spa Patient Prescribing
    • Galderma Launches Alastin Regenerating Skin Nectar with TriHex+
    • FDA Moves to Reevaluate Several Peptides